# Post-market Prospective, Multicenter, Randomized and Single-blinded Clinical Investigation to Evaluate Whether Cardiac Re-Synchronization Therapy (CRT) Using Automatic Continuous Atrioventricular (AV) Delay Optimization is Superior to CRT With Conventional Biventricular Stimulation (BiV).

Study · id `cardio:ct-nct06044597` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06044597](<https://clinicaltrials.gov/study/NCT06044597>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06044597

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 722 participants.

## Technical summary

Registry record NCT06044597. Randomized; no masking; primary purpose treatment. Start 2023-10-01 (anticipated); primary completion 2026-04-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 722 participants (planned count; ClinicalTrials.gov record NCT06044597, source copy `cardio:ctgov-nct06044597-2023-09-21`, retrieved 2026-11-18)
- Planned start: 2023-10-01 (anticipated) (ClinicalTrials.gov record NCT06044597, source copy `cardio:ctgov-nct06044597-2023-09-21`, retrieved 2026-11-18)
- Primary completion: 2026-04-30 (anticipated) (ClinicalTrials.gov record NCT06044597, source copy `cardio:ctgov-nct06044597-2023-09-21`, retrieved 2026-11-18)
- Completion: 2026-10-30 (anticipated) (ClinicalTrials.gov record NCT06044597, source copy `cardio:ctgov-nct06044597-2023-09-21`, retrieved 2026-11-18)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06044597-2023-09-21`, retrieved 2026-11-18)

## The registry's words

- Brief title: Post-market Prospective, Multicenter, Randomized and Single-blinded Clinical Investigation to Evaluate Whether Cardiac Re-Synchronization Therapy (CRT) Using Automatic Continuous Atrioventricular (AV) Delay Optimization is Superior to CRT With Conventional Biventricular Stimulation (BiV).
- Acronym: CRUSTY +
- Condition: Heart Failure
- Intervention (Device): SyncAV function on
- Lead sponsor: Antonio Rapacciuolo
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: 9df6e19b107a6c02ce1555db0d329e153666233f63bcef207aff310f6a4eb5f7
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
